Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2026
Employees
73,500
Siemens Healthineers AG News & Analysis
stocks
3 overvalued ASX stocks with cheaper alternatives
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,293.20 | 45.10 | -0.48% |
CAC 40 | 8,189.52 | 0.93 | 0.01% |
DAX 40 | 23,830.99 | 441.20 | -1.82% |
Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
FTSE 100 | 9,348.01 | 88.08 | -0.93% |
HKSE | 25,247.10 | 641.41 | -2.48% |
NASDAQ | 22,679.97 | 117.44 | 0.52% |
Nikkei 225 | 47,582.15 | 695.59 | -1.44% |
NZX 50 Index | 13,289.21 | 99.89 | -0.75% |
S&P 500 | 6,664.01 | 34.94 | 0.53% |
S&P/ASX 200 | 8,995.30 | 34.70 | -0.38% |
SSE Composite Index | 3,839.76 | 76.47 | -1.95% |